Abstract
Heparin and glycosaminoglycans (GAGs) related structurally to heparin, notably heparan sulphate, bind to most, if not all, chemokines and many growth factors. The chemokine and growth factor interactions with GAGs localise the peptide mediators to specific sites in tissues and influence their stability and function. This chapter discusses the nature of these interactions and the effect on the function of a number of chemokines (PF-4, interleukin-8, RANTES and SDF-1) and growth factors (FGF, HGF, VEGF) in normal physiology and the disease setting. Novel therapeutic interventions that target chemokine and growth factor interactions with GAGs are also discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Alexopoulou AN, Multhaupt HAB, Couchman JR (2007) Syndecans in wound healing, inflammation and vascular biology. Int J Biochem Cell Biol 39:505–528
Bedke J, Nelson PJ, Kiss E et al (2010) A novel CXCL8 protein-based antagonist in acute experimental renal allograft damage. Mol Immunol 47(5):1047–1057
Beenken A, Mohammadi M (2009) The FGF family: biology, pathophysiology and therapy. Nat Rev Drug Discov 8:235–253
Belpeiro JA, Keane MP, Arenberg DA et al (2000) CXC chemokines in angiogenesis. J Leukoc Biol 68:1–8
Birchmeier C, Birchmeier W, Gheradi E, van de Woude GF (2003) MET, metastasis, motility and more. Nat Rev Mol Cell Biol 4:915–925
Bishop JR, Schuksz M, Esko JD (2007) Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature 446:1030–1037
Brandner B, Rek A, Diedrichs-Mohring M et al (2009) Engineering the glycosaminoglycan-binding affinity, kinetics and oligomerization behaviour of RANTES: a tool for generating chemokine-based glycosaminoglycan antagonists. Prot Eng Des Select 22:367–373
Brandt E, Ludwig A, Petersen F, Flad H-D (2000) Platelet-derived CXC chemokines: old players in new games. Immunol Rev 177:204–216
Capila I, Linhardt RJ (2002) Heparin-protein interaction. Angew Chem Int Ed Engl 41:390–412
Catlow KR, Deakin JA, Wei Z et al (2008) Interactions of hepatocyte growth factor/scatter factor with various glycosaminoglycans reveal an important interplay between the presence of iduronate and sulphate density. J Biol Chem 283:5235–5248
Charnaux N, Brule S, Hamon M et al (2005) Syndecan-4 is a signalling molecule for stromal cell-derived factor-1 (SDF-1)/CXCL12. FEBS J 272:1937–1951
Charni F, Friand V, Haddad O et al (2009) Syndecan-1 and syndecan-4 are involved in RANTES/CCL5-induced migration and invasion of human hepatoma cells. Biochim Biophys Acta 1790:1314–1326
Colditz IG, Schneider MA, Pruenster M, Rot A (2007) Chemokines at large: in-vivo mechanisms of their transport, presentation and clearance. Thromb Haemost 97:688–693
De Larco JE, Wuertz BRK, Furcht LT (2004) The potential role of neutrophils in promoting the metastatic phenotype of tumours releasing interleukin-8. Clin Cancer Res 10:4895–4900
de Paz JL, Moseman EA, Noti C et al (2007) Profiling heparan-chemokine interactions using synthetic tools. ACS Chem Biol 2:735–744
Ferro V, Dredge K, Liu L et al (2007) PI-88 and novel heparan sulphate mimetics inhibit angiogenesis. Semin Thromb Hemost 33:557–568
Freeman C, Liu L, Banwell MG et al (2005) Use of sulphated linked cyclitols as heparan sulphate mimetics to probe the heparin/heparan sulphate binding specificity of proteins. J Biol Chem 280:8842–8849
Frevert CW, Kinsella MG, Vathanaprida C et al (2003) Binding of interleukin-8 to heparan sulfate and chondroitin sulfate in lung tissue. Am J Respir Cell Mol Biol 28:464–472
Gallagher JT (2006) Multiprotein signalling complexes: regional assembly on heparan sulphate. Biochem Soc Trans 34:438–441
Gandhi NS, Mancera RL (2008) The structure of glycosaminoglycans and their interactions with proteins. Chem Biol Drug Des 72:455–482
Gleissner CA, von Hundelhausen P, Ley K (2008) Platelet chemokines in vascular disease. Arterioscler Thromb Vasc Biol 28:1920–1927
Goodger SJ, Robinson CJ, Murphy KJ et al (2008) Evidence that heparin saccharides promote FGF2 mitogenesis through two distinct mechanisms. J Biol Chem 283:13001–13008
Greinacher A (2009) Heparin-induced thrombocytopenia. J Thromb Haemost 7:9–12
Halden Y, Rek A, Atzenhofer W et al (2004) Interleukin-8 binds to syndecan-2 on human endothelial cells. Biochem J 377:533–538
Handel TM, Johnson Z, Crown SE et al (2005) Regulation of protein function by glycosaminoglycans – as exmplified by chemokines. Annu Rev Biochem 74:385–410
Harmer NJ (2006) Insights into the role of heparan sulphate in fibroblast growth factor signalling. Biochem Soc Trans 34:442–445
Hoogewerf AJ, Kushert GSV, Proudfoot AEI et al (1997) Glycosaminoglycans mediate cell surface oligomerisation of chemokines. Biochemistry 36:13570–13578
Johnson Z, Kosco-Vilbois MH, Herren S et al (2004) Interference with heparin binding and oligomerisation creates a novel anti-inflammatory strategy targeting the chemokine system. J Immunol 173:5776–5785
Joung YK, Bae JW, Park KD (2008) Controlled release of heparin-binding growth factors using heparin-containing particulate systems for tissue regeneration. Expert Opin Drug Deliv 5:1173–1184
Kato M, Wang H, Kainulainen V et al (1998) Physiological degradation converts the soluble syndecan-1 ectodomain from an inhibitor to a potent activator of FGF-2. Nat Med 4:691–697
Khachigian LM, Parish CR (2004) Phosphomannopentaose sulphate (PI-88): heparan sulphate mimetic with clinical potential in multiple vascular pathologies. Cardiovasc Drug Rev 22:1–6
Kreuger J, Spillman D, Li J-P, Lindahl U (2006) Interactions between heparan sulfate and proteins: the concept of specificity. J Cell Biol 174:323–327
Kuschert GS, Hoogewerf AJ, Proudfoot AE et al (1998) Identification of a glycosaminoglycan binding surface on human interleukin-8. Biochemistry 37:11193–11201
Kuschert GSV, Coulin F, Power CA et al (1999) Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses. Biochemistry 38:12959–12968
Ley K, Laudanna C, Cybulsky MI, Nourshargh S (2007) Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol 7:678–689
Li Q, Park PW, Wilson CL, Parks WC (2002) Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury. Cell 111:635–646
Lortat-Jacob H (2009) The molecular basis and functional implications of chemokine interactions with heparan sulphate. Curr Opin Struct Biol 19:543–548
Lortat-Jacob H, Grosdidier A, Imberty A (2002) Structural diversity of heparan sulphate binding domains in chemokines. Proc Natl Acad Sci USA 99:1229–1234
Malavaki C, Mizumoto N, Karamanos N, Sugahara K (2008) Recent advances in the structural study of functional chondroitin and dermatan sulphate in health and disease. Conn Tiss Res 49:133–139
Marshall LJ, Ramdin LS, Brooks T et al (2003) Plasminogen activator inhibitor-1 supports IL-8-mediated neutrophil transendothelial migration by inhibition of the constitutive shedding of endothelial IL-8/heparan sulfate/syndecan-1 complexes. J Immunol 171:2057–65
Martin L, Blanpain C, Garnier P et al (2001) Structural and functional analysis of the RANTES-glycosaminoglycans interactions. Biochemistry 40:6303–6318
Masouleh BK, Ten Dam GB, Wild MK et al (2009) Role of heparan sulphate proteoglycan syndecan-1 (CD138) in delayed type hypersensitivity. J Immunol 182:4985–4993
Mikhailov D, Young HC, Linhardt RJ, Mayo KH (1999) Heparin dodecasaccaride binding to platelet factor-4 and growth-related protein-alpha. Induction of a partially folded state and implications for heparin-induced thrombocytopenia. J Biol Chem 274:25317–25329
Murphy JW, Cho Y, Sachpatzidis A et al (2007) Structural and functional basis of CXCL12 (stromal cell-derived factor-1 alpha) binding to heparin. J Biol Chem 282:10018–10027
Nickel W (2007) Unconventional secretion: an extracellular trap for export of fibroblast growth factor 2. J Cell Sci 120:2295–2299
Parish CR (2006) The role of heparan sulphate in inflammation. Nat Rev Immunol 6:633–643
Patterson AM, Gardner L, Shaw J et al (2005) Induction of a CXCL8 binding site on endothelial syndecan-3 in rheumatoid synovium. Arthritis Rheum 52:2331–2342
Poncz M (2005) Mechanistic basis of heparin-induced thrombocytopenia. Semin Thorac Cardiovasc Surg 17:73–79
Proudfoot AE, Fritchley S, Borlat F et al (2001) The BBXB motif of RANTES is the principal site for heparin binding and controls receptor selectivity. J Biol Chem 276:10620–10626
Proudfoot AE, Handel TM, Johnson Z et al (2003) Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines. Proc Natl Acad Sci USA 100:1885–1890
Proudfoot AEI, de Souza ALS, Muzio V (2008) The use of chemokine antagonists in EAE models. J Neuroimmunol 198:27–30
Rajarathnam K, Sykes BD, Kay CM et al (1994) Neutrophil activation by monomeric interleukin-8. Science 264:90–92
Ramdin L, Perks B, Sheron N, Shute JK (1997) Regulation of interleukin-8 binding and function by heparin and alpha2-macroglobulin. Clin Exp Allergy 28:616–624
Rek A, Brandner B, Geretti E, Kungl AJ (2009a) A biophysical insight into the RANTES-glycoaminoglycan interaction. Biochim Biophys Acta 1794:577–582
Rek A, Krenn E, Kungl AJ (2009b) Therapeutically targeting protein-glycan interactions. Br J Pharmacol 157:686–694
Robinson CJ, Mulloy B, Gallagher JT, Stringer SE (2006) VEGF165-binding sites within heparan sulphate encompass two highly sulphated domains and can be liberated by K5 lyase. J Biol Chem 281:1731–1740
Rot A (1992) Endothelial cell binding of NAP-1/IL-8: role in neutrophil emigration. Immunol Today 13:291–294
Rot A, Hub E, Middleton J et al (1996) Some aspects of IL-8 pathophysiology III: chemokine interaction with endothelial cells. J Lukoc Biol 59:39–44
Rueda P, Balabanian K, Lagane B et al (2008) The CXCL12γ chemokine displays unprecedented structural ad functional properties that make it a paradigm of chemoattractant proteins. PLoS One 3:e2543
Ruhrberg C (2003) Growing and shaping the vascular tree: multiple roles for VEGF. Bioessays 25:1052–1060
Schuksz M, Fuster MM, Brown JR et al (2008) Surfen, a small molecule antagonist of heparan sulphate. Proc Natl Acad Sci USA 105:13075–13080
Segerer S, Johnson Z, Rek A et al (2009) The basic residue cluster 55KKWVR59 in CCL5 is required for in vivo biologic function. Mol Immunol 46:2533–2538
Shamri R, Grabovsky V, Gauguet JM et al (2005) Lymphocyte arrest requires instantaneous induction of an extended LFA-1 conformation mediated by endothelium-bound chemokines. Nat Immunol 6:497–506
Solic N, Wilson J, Wilson SJ, Shute JK (2005) Endothelial activation and increased heparan sulfate expression in cystic fibrosis. Am J Respir Crit Care Med 72:892–898
Spillman D, Witt D, Lindahl U (1998) Defining the interleukin-8 binding domain of heparan sulphate. J Biol Chem 273:15487–15493
Stringer SE, Gallagher JT (1997) Specific binding of the chemokine platelet factor 4 to heparan sulphate. J Biol Chem 272:20508–20514
Sutton A, Friand V, Papy-Garcia D et al (2007) Glycosaminoglycans and their synthetic mimetics inhibit RANTES-induced migration and invasion of human hepatoma cells. Mol Cancer Ther 6:2948–2958
Taipale J, Keski-Oja J (1997) Growth factors in the extracellular matrix. FASEB J 11:51–59
Wagner L, Yang OO, Garcia-Zepeda EA et al (1998) Beta-chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans. Nature 391(6670):908–911
Wang L, Fuster M, Sriramarao P, Esko JD (2005) Endothelial heparan sulphate deficiency impairs L-selectin- and chemokine-mediated neutrophil trafficking during inflammatory responses. Nat Immunol 6:902–910
Waugh DJJ, Wilson C (2008) The interleukin-8 pathway in cancer. Clin Cancer Res 14:6735–6741
Xiao Z, Visentin GP, Dayananda K, Neelamegham S (2008) Immune complexes formed following the binding of anti-platelet factor 4 (CXCL4) antibodies to CXCL4 stimulate human neutrophil activation and cell adhesion. Blood 112:1091–1100
Xu J, Park PW, Kheradmand F, Corry DB (2005) Endogenous attenuation of allergic lung inflammation by syndecan-1. J Immunol 174:5758–5765
Yamaguchi K, Tamaki H, Fukui S (2006) Detection of oligosaccharide ligands for hepatocyte growth factor/scatter factor (HGF/SF), keratinocyte growth factor (KGF/FGF-7), RANTES and heparin cofactor II by neoglycolipid microarrays of glycosaminoglycan-derived oligosaccharide fragments. Glycoconj J 23:513–523
Yoshimura T, Matsushima K, Tanaka S et al (1987) Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host-defense cytokines. Proc Natl Acad Sci USA 84:9233–9237
Zlotnik A, Yoshie O, Nomiyama H (2006) The chemokine and chemokine receptor superfamilies and their molecular evolution. Genome Biol 7:243
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Shute, J. (2012). Glycosaminoglycan and Chemokine/Growth Factor Interactions. In: Lever, R., Mulloy, B., Page, C. (eds) Heparin - A Century of Progress. Handbook of Experimental Pharmacology, vol 207. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-23056-1_13
Download citation
DOI: https://doi.org/10.1007/978-3-642-23056-1_13
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-23055-4
Online ISBN: 978-3-642-23056-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)